SlideShare a Scribd company logo
FETAL BLOOD SAMPLING
AND CORD GASES
BUSHRA SAEED
CHINONYE ANYANWU
UMAR HUSSAIN
HINCHINGBROOKE HOSPITAL, HUNTINGDON, CAMBRIDGESHIRE, UNITED
KINGDOM
BACKGROUND
• Used in conjunction with continuous fetal heart rate monitoring, fetal
blood sampling enables practitioners to interpret the level of fetal
compromise and ascertain the safest way forward
• The local guideline gives clear pathways for interpreting and
documenting these results and the actions that should follow
• Adhering to this means that CNST Level 3 Standard is achieved
REFERENCES
• National Institute for Health and Clinical Excellence. (CG 190, 2014).
Intrapartum care of healthy women and babies.
• National Health Service Litigation Authority. (2009). NHS Litigation Authority
Study Of Stillbirth Claims. London: NHSLA. Available at: www.nhsla.com
• Royal College of Anaesthetists, Royal College of Midwives, Royal College of
Obstetricians and Gynaecologists, Royal College of Paediatrics and Child
Health. (2007). Safer Childbirth: Minimum Standards for the Organisation
and Delivery of Care in Labour. London: RCOG Press. Available at:
www.rcog.org.uk
SPECIFIC OBJECTIVES
• To ensure that:
• The documentation of FBS results in the health record is correct
• Requirement and timing of repeated FBS with appropriate documentation
follows guideline
• Correct documentation of paired samples in the health record
AUDIT CRITERIA
Criterion Std expected
All FBS results documented in intrapartum notes 75%
All FBS results documented in black ink? 75%
For paired results, cord gases documented on p. 20 of intrapartum notes? 75%
Paired results documented in black ink? 75%
Paper print outs for FBS secured to intrapartum notes? 75%
Paper print outs for cord gases secured to intrapartum notes? 75%
Appropriate reason for FBS given? 75%
If repeated, within guideline timeframe? 75%
If third FBS performed, Consultant informed? 75%
METHODOLOGY
• 20 cases during the year January 2015 to January 2016 were used for
each arm of audit
• 2 part Audit: FBS and Paired cord sample without FBS
• Identified via maternity database as having had FBS or paired
samples
• Modified audit tool to measure against
METHODOLOGY DETAILS TO ALLOW EXACT
REPLICATION OF PROJECT
1: SAMPLE
• 20 cases audited
• Method of selection: cases highlighted by delivery database as having
had an FBS or paired cord samples
• Retrospective audit
METHODOLOGY DETAILS
PROFORMA
Q1 Hospital Number Yes No N/A
Q2 All FBS results documented in intrapartum notes?
Q3 All FBS results documented in black ink?
Q4 For paired results, cord gases documented on p. 20 of intrapartum notes?
Q5 Paired results documented in black ink?
Q6
Paper print outs for FBS secured to intrapartum notes?
Q7
Paper print outs for cord gases secured to intrapartum notes?
Q8
Appropriate reason for FBS given?
Q9 Repetition of FBS required as per guideline?
Q10
Repetition of FBS performed?
Q11 If repeated, within guideline timeframe?
Q12
If third FBS performed, Consultant informed?
RESULTS: FBS AUDIT (20 FBS PERFORMED )
Question % Achieved
1 Reason for FBS 100
2 Contraindications: 1 case only Sepsis N/A
3 Reason for not performing FBS documented 100
4 If acute compromise, FBS performed within 30 mins from bradycardia
(0 cases)
N/A
5 If acute compromise, FBS performed after 30 mins of recovery from
bradycardia (0 cases)
N/A
6 FBS documented: 100
7 Repeat FBS , results put in context (6 repeats) 100
8 If CTG pathological, repeat FBS no later than 1 hr (1 cases) 100
RESULTS: FBS AUDIT (20 FBS
PERFORMED)
Question % Achieved
9 FBS borderline, repeat FBS within 30 mins: 0
cases ( 1 case ,opted for EMCS)
N/A
10 If CTG unchanged, third FBS deferred ( 0 cases) N/A
11 3rd FBS, consultant opinion prior: 2 case opted
for EMCS
100
12 Failed FBS: Consultant informed : 1 case 100
13 Abnormal 3rd FBS, consultant informed: 0 cases N/A
14 Paired cord sample after birth: 20 cases 100
RESULTS: PAIRED CORD SAMPLE
WITHOUT FBS , 20 CASES
Question % Achieved
1 Reason for sample 100
2 If result abnormal, Paeds informed (19
cases, 1case normal results)
100
3 If paeds informed, plan of action by Paeds
(All 19 cases)
100
4 Result of paired sample documented: All 19
cases all criteria
100
CONCLUSIONS
Criterion Standard
Achieved 2016 (%)
(Standard achieved
2013)
All FBS results documented in intrapartum notes 100 (100)
All FBS results documented in black ink? 100 (100)
For paired results, cord gases documented on p. 20 of intrapartum notes? 100 (84)
Paired results documented in black ink? 95 (84)
Paper print outs for FBS secured to intrapartum notes? 100 (95)
Paper print outs for cord gases secured to intrapartum notes? 100 (87)
Appropriate reason for FBS given? 100 (100)
If repeated, within guideline timeframe? 100 (100)
If third FBS performed, Consultant informed? 100 (100)
ACTION PLAN
• Inform clinicians/ midwives at their induction that cord
gases must be documented in and print outs securely
fixed within intrapartum notes
• Continue to highlight at LSCS and Senior Midwife
meetings,
• induction of medical staff,
• User guide on gas machine
DISCUSSIONS / POINTS FROM
PRESENTATION / MEETINGS
• CNST standards achieved
• Close the audit loop
• Recommendations to continue current practice

More Related Content

Similar to Fetal blood sampling and cord gases

PROM
PROMPROM
NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre
Lifecare Centre
 
Ls,infertility 2007
Ls,infertility 2007Ls,infertility 2007
Ls,infertility 2007
Adnan Dizboyu
 
IS IT ENDING OF START ERA
IS IT ENDING OF START ERAIS IT ENDING OF START ERA
IS IT ENDING OF START ERA
Kanhu Charan
 
ISQua 2008 - QOF and diabetes
ISQua 2008 - QOF and diabetesISQua 2008 - QOF and diabetes
ISQua 2008 - QOF and diabetes
Evangelos Kontopantelis
 
Two-Tier Newborn Screening for Cystic Fibrosis (in Virginia)
Two-Tier Newborn Screening for Cystic Fibrosis (in Virginia)Two-Tier Newborn Screening for Cystic Fibrosis (in Virginia)
Two-Tier Newborn Screening for Cystic Fibrosis (in Virginia)
kas3b
 
Expanded newborn screening
Expanded newborn screeningExpanded newborn screening
Expanded newborn screening
PHEScreening
 
Cochrane
CochraneCochrane
Cochrane
Hesham Al-Inany
 
Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.pptCongenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
ssuseree565d
 
Reporting and interpretation of laboratory results
Reporting and interpretation of laboratory resultsReporting and interpretation of laboratory results
Reporting and interpretation of laboratory results
Joyce Mwatonoka
 
UOG Journal Club: September 2016
UOG Journal Club: September 2016UOG Journal Club: September 2016
Spitzer datawarehouse
Spitzer datawarehouseSpitzer datawarehouse
Spitzer datawarehouse
Mitzi Santiago
 
UOG Journal Club: Multicenter screening for pre-eclampsia by maternal factors...
UOG Journal Club: Multicenter screening for pre-eclampsia by maternal factors...UOG Journal Club: Multicenter screening for pre-eclampsia by maternal factors...
UOG Journal Club: Multicenter screening for pre-eclampsia by maternal factors...
International Society of Ultrasound in Obstetrics and Gynecology (ISUOG)
 
Landmark trials in breast cancer.pptx
Landmark trials in breast cancer.pptxLandmark trials in breast cancer.pptx
Landmark trials in breast cancer.pptx
Namrata Das
 
Selective embryo-fetal reduction
Selective embryo-fetal reductionSelective embryo-fetal reduction
Selective embryo-fetal reduction
Sofía Fournier Fisas
 
The role of bowel preparation in colorectal surgery
The role of bowel preparation in colorectal surgeryThe role of bowel preparation in colorectal surgery
The role of bowel preparation in colorectal surgery
Shaurya Pratap Singh
 
Pregnancy Outcomes of Oligohydramnios at Term diagnosed by Ultra Sonography (...
Pregnancy Outcomes of Oligohydramnios at Term diagnosed by Ultra Sonography (...Pregnancy Outcomes of Oligohydramnios at Term diagnosed by Ultra Sonography (...
Pregnancy Outcomes of Oligohydramnios at Term diagnosed by Ultra Sonography (...
International Multispeciality Journal of Health
 
Fetal surveillance 2020
Fetal surveillance 2020Fetal surveillance 2020
Fetal surveillance 2020
DrRabirraWaktola
 
1. Antenatal screening updates
1. Antenatal screening updates1. Antenatal screening updates
1. Antenatal screening updates
PHEScreening
 
Maximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by IndividualizationMaximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by Individualization
Sandro Esteves
 

Similar to Fetal blood sampling and cord gases (20)

PROM
PROMPROM
PROM
 
NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre
 
Ls,infertility 2007
Ls,infertility 2007Ls,infertility 2007
Ls,infertility 2007
 
IS IT ENDING OF START ERA
IS IT ENDING OF START ERAIS IT ENDING OF START ERA
IS IT ENDING OF START ERA
 
ISQua 2008 - QOF and diabetes
ISQua 2008 - QOF and diabetesISQua 2008 - QOF and diabetes
ISQua 2008 - QOF and diabetes
 
Two-Tier Newborn Screening for Cystic Fibrosis (in Virginia)
Two-Tier Newborn Screening for Cystic Fibrosis (in Virginia)Two-Tier Newborn Screening for Cystic Fibrosis (in Virginia)
Two-Tier Newborn Screening for Cystic Fibrosis (in Virginia)
 
Expanded newborn screening
Expanded newborn screeningExpanded newborn screening
Expanded newborn screening
 
Cochrane
CochraneCochrane
Cochrane
 
Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.pptCongenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
 
Reporting and interpretation of laboratory results
Reporting and interpretation of laboratory resultsReporting and interpretation of laboratory results
Reporting and interpretation of laboratory results
 
UOG Journal Club: September 2016
UOG Journal Club: September 2016UOG Journal Club: September 2016
UOG Journal Club: September 2016
 
Spitzer datawarehouse
Spitzer datawarehouseSpitzer datawarehouse
Spitzer datawarehouse
 
UOG Journal Club: Multicenter screening for pre-eclampsia by maternal factors...
UOG Journal Club: Multicenter screening for pre-eclampsia by maternal factors...UOG Journal Club: Multicenter screening for pre-eclampsia by maternal factors...
UOG Journal Club: Multicenter screening for pre-eclampsia by maternal factors...
 
Landmark trials in breast cancer.pptx
Landmark trials in breast cancer.pptxLandmark trials in breast cancer.pptx
Landmark trials in breast cancer.pptx
 
Selective embryo-fetal reduction
Selective embryo-fetal reductionSelective embryo-fetal reduction
Selective embryo-fetal reduction
 
The role of bowel preparation in colorectal surgery
The role of bowel preparation in colorectal surgeryThe role of bowel preparation in colorectal surgery
The role of bowel preparation in colorectal surgery
 
Pregnancy Outcomes of Oligohydramnios at Term diagnosed by Ultra Sonography (...
Pregnancy Outcomes of Oligohydramnios at Term diagnosed by Ultra Sonography (...Pregnancy Outcomes of Oligohydramnios at Term diagnosed by Ultra Sonography (...
Pregnancy Outcomes of Oligohydramnios at Term diagnosed by Ultra Sonography (...
 
Fetal surveillance 2020
Fetal surveillance 2020Fetal surveillance 2020
Fetal surveillance 2020
 
1. Antenatal screening updates
1. Antenatal screening updates1. Antenatal screening updates
1. Antenatal screening updates
 
Maximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by IndividualizationMaximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by Individualization
 

Recently uploaded

Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
PVI, PeerView Institute for Medical Education
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Gokuldas Hospital
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 

Recently uploaded (20)

Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 

Fetal blood sampling and cord gases

  • 1. FETAL BLOOD SAMPLING AND CORD GASES BUSHRA SAEED CHINONYE ANYANWU UMAR HUSSAIN HINCHINGBROOKE HOSPITAL, HUNTINGDON, CAMBRIDGESHIRE, UNITED KINGDOM
  • 2. BACKGROUND • Used in conjunction with continuous fetal heart rate monitoring, fetal blood sampling enables practitioners to interpret the level of fetal compromise and ascertain the safest way forward • The local guideline gives clear pathways for interpreting and documenting these results and the actions that should follow • Adhering to this means that CNST Level 3 Standard is achieved
  • 3. REFERENCES • National Institute for Health and Clinical Excellence. (CG 190, 2014). Intrapartum care of healthy women and babies. • National Health Service Litigation Authority. (2009). NHS Litigation Authority Study Of Stillbirth Claims. London: NHSLA. Available at: www.nhsla.com • Royal College of Anaesthetists, Royal College of Midwives, Royal College of Obstetricians and Gynaecologists, Royal College of Paediatrics and Child Health. (2007). Safer Childbirth: Minimum Standards for the Organisation and Delivery of Care in Labour. London: RCOG Press. Available at: www.rcog.org.uk
  • 4. SPECIFIC OBJECTIVES • To ensure that: • The documentation of FBS results in the health record is correct • Requirement and timing of repeated FBS with appropriate documentation follows guideline • Correct documentation of paired samples in the health record
  • 5. AUDIT CRITERIA Criterion Std expected All FBS results documented in intrapartum notes 75% All FBS results documented in black ink? 75% For paired results, cord gases documented on p. 20 of intrapartum notes? 75% Paired results documented in black ink? 75% Paper print outs for FBS secured to intrapartum notes? 75% Paper print outs for cord gases secured to intrapartum notes? 75% Appropriate reason for FBS given? 75% If repeated, within guideline timeframe? 75% If third FBS performed, Consultant informed? 75%
  • 6. METHODOLOGY • 20 cases during the year January 2015 to January 2016 were used for each arm of audit • 2 part Audit: FBS and Paired cord sample without FBS • Identified via maternity database as having had FBS or paired samples • Modified audit tool to measure against
  • 7. METHODOLOGY DETAILS TO ALLOW EXACT REPLICATION OF PROJECT 1: SAMPLE • 20 cases audited • Method of selection: cases highlighted by delivery database as having had an FBS or paired cord samples • Retrospective audit
  • 8. METHODOLOGY DETAILS PROFORMA Q1 Hospital Number Yes No N/A Q2 All FBS results documented in intrapartum notes? Q3 All FBS results documented in black ink? Q4 For paired results, cord gases documented on p. 20 of intrapartum notes? Q5 Paired results documented in black ink? Q6 Paper print outs for FBS secured to intrapartum notes? Q7 Paper print outs for cord gases secured to intrapartum notes? Q8 Appropriate reason for FBS given? Q9 Repetition of FBS required as per guideline? Q10 Repetition of FBS performed? Q11 If repeated, within guideline timeframe? Q12 If third FBS performed, Consultant informed?
  • 9. RESULTS: FBS AUDIT (20 FBS PERFORMED ) Question % Achieved 1 Reason for FBS 100 2 Contraindications: 1 case only Sepsis N/A 3 Reason for not performing FBS documented 100 4 If acute compromise, FBS performed within 30 mins from bradycardia (0 cases) N/A 5 If acute compromise, FBS performed after 30 mins of recovery from bradycardia (0 cases) N/A 6 FBS documented: 100 7 Repeat FBS , results put in context (6 repeats) 100 8 If CTG pathological, repeat FBS no later than 1 hr (1 cases) 100
  • 10. RESULTS: FBS AUDIT (20 FBS PERFORMED) Question % Achieved 9 FBS borderline, repeat FBS within 30 mins: 0 cases ( 1 case ,opted for EMCS) N/A 10 If CTG unchanged, third FBS deferred ( 0 cases) N/A 11 3rd FBS, consultant opinion prior: 2 case opted for EMCS 100 12 Failed FBS: Consultant informed : 1 case 100 13 Abnormal 3rd FBS, consultant informed: 0 cases N/A 14 Paired cord sample after birth: 20 cases 100
  • 11. RESULTS: PAIRED CORD SAMPLE WITHOUT FBS , 20 CASES Question % Achieved 1 Reason for sample 100 2 If result abnormal, Paeds informed (19 cases, 1case normal results) 100 3 If paeds informed, plan of action by Paeds (All 19 cases) 100 4 Result of paired sample documented: All 19 cases all criteria 100
  • 12. CONCLUSIONS Criterion Standard Achieved 2016 (%) (Standard achieved 2013) All FBS results documented in intrapartum notes 100 (100) All FBS results documented in black ink? 100 (100) For paired results, cord gases documented on p. 20 of intrapartum notes? 100 (84) Paired results documented in black ink? 95 (84) Paper print outs for FBS secured to intrapartum notes? 100 (95) Paper print outs for cord gases secured to intrapartum notes? 100 (87) Appropriate reason for FBS given? 100 (100) If repeated, within guideline timeframe? 100 (100) If third FBS performed, Consultant informed? 100 (100)
  • 13. ACTION PLAN • Inform clinicians/ midwives at their induction that cord gases must be documented in and print outs securely fixed within intrapartum notes • Continue to highlight at LSCS and Senior Midwife meetings, • induction of medical staff, • User guide on gas machine
  • 14. DISCUSSIONS / POINTS FROM PRESENTATION / MEETINGS • CNST standards achieved • Close the audit loop • Recommendations to continue current practice